Advertisement

Performance of preoperative breast MRI based on breast cancer molecular subtype

      Highlights

      • Breast cancer molecular subtype did not influence biopsy recommendations on preoperative MRI.
      • The positive predictive value of biopsies was not influenced by molecular subtype
      • A true positive biopsy increased the likelihood of mastectomy.

      Abstract

      Purpose

      To assess the performance of preoperative breast MRI biopsy recommendations based on breast cancer molecular subtype.

      Methods

      All preoperative breast MRIs at a single academic medical center from May 2010 to March 2014 were identified. Reports were reviewed for biopsy recommendations. All pathology reports were reviewed to determine biopsy recommendation outcomes. Molecular subtypes were defined as Luminal A (ER/PR+ and HER2-), Luminal B (ER/PR+ and HER2+), HER2 (ER-, PR- and HER2+), and Basal (ER-, PR-, and HER2-). Logistic regression assessed the probability of true positive versus false positive biopsy and mastectomy versus lumpectomy.

      Results

      There were 383 patients included with a molecular subtype distribution of 253 Luminal A, 44 Luminal B, 20 HER2, and 66 Basal. Two hundred and thirteen (56%) patients and 319 sites were recommended for biopsy. Molecular subtype did not influence the recommendation for biopsy (p = 0.69) or the number of biopsy site recommendations (p = 0.30). The positive predictive value for a biopsy recommendation was 42% overall and 46% for Luminal A, 43% for Luminal B, 36% for HER2, and 29% for Basal subtype cancers. The multivariate logistic regression model showed no difference in true positive biopsy rate based on molecular subtype (p = 0.78). Fifty-one percent of patients underwent mastectomy and the multivariate model demonstrated that only a true positive biopsy (odds ratio: 5.3) was associated with higher mastectomy rates.

      Conclusion

      Breast cancer molecular subtype did not influence biopsy recommendations, positive predictive values, or surgical approaches. Only true positive biopsies increased the mastectomy rate.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stout N.K.
        • Nekhlyudov L.
        • Li L.
        • Malin E.S.
        • Ross-Degnan D.
        • Buist D.S.
        • et al.
        Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.
        JAMA Intern Med. 2014; 174: 114-121
        • Tseng J.
        • Kyrillos A.
        • Liederbach E.
        • Spear G.G.
        • Ecanow J.
        • Wang C.H.
        • et al.
        Clinical accuracy of preoperative breast MRI for breast cancer.
        J Surg Oncol. 2017; 115: 924-931
        • Vos E.L.
        • Voogd A.C.
        • Verhoef C.
        • Siesling S.
        • Obdeijn I.M.
        • Koppert L.B.
        Benefits of preoperative MRI in breast cancer surgery studied in a large population-based cancer registry.
        Br J Surg. 2015; 102: 1649-1657
        • Houssami N.
        • Turner R.M.
        • Morrow M.
        Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer.
        Breast Cancer Res Treat. 2017; 165: 273-283
        • Houssami N.
        • Turner R.
        • Morrow M.
        Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes.
        Ann Surg. 2013; 257: 249-255
        • Sung J.S.
        • Li J.
        • Da Costa G.
        • Patil S.
        • Van Zee K.J.
        • Dershaw D.D.
        • et al.
        Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes.
        AJR Am J Roentgenol. 2014; 202: 1376-1382
        • Choi W.J.
        • Cha J.H.
        • Kim H.H.
        • Shin H.J.
        • Chae E.Y.
        • Jung K.H.
        • et al.
        Long-term survival outcomes of primary breast cancer in women with or without preoperative magnetic resonance imaging: a matched cohort study.
        Clin Oncol (R Coll Radiol). 2017; 29: 653-661
        • Turnbull L.
        • Brown S.
        • Harvey I.
        • Olivier C.
        • Drew P.
        • Napp V.
        • et al.
        Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial.
        Lancet. 2010; 375: 563-571
        • Gonzalez V.
        • Sandelin K.
        • Karlsson A.
        • Aberg W.
        • Lofgren L.
        • Iliescu G.
        • et al.
        Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study.
        World J Surg. 2014; 38: 1685-1693
        • Parsyan A.
        • Moldoveanu D.
        • Balram B.
        • Wong S.
        • Zhang D.D.
        • Svadzian A.
        • et al.
        Influence of preoperative magnetic resonance imaging on the surgical management of breast cancer patients.
        Am J Surg. 2016; 211: 1089-1094
        • Haque W.
        • Verma V.
        • Hatch S.
        • Suzanne Klimberg V.
        • Brian Butler E.
        • Teh B.S.
        Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy.
        Breast Cancer Res Treat. 2018; 170: 559-567
        • Lobbes M.B.
        • Vriens I.J.
        • van Bommel A.C.
        • Nieuwenhuijzen G.A.
        • Smidt M.L.
        • Boersma L.J.
        • et al.
        Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.
        Breast Cancer Res Treat. 2017; 162: 353-364
        • F S
        Preoperative staging with MRI: Did the MIPA trial solve all issues?.
        2018
        • Seely J.M.
        • Lamb L.
        • Malik N.
        • Lau J.
        The yield of pre-operative breast MRI in patients according to breast tissue density.
        Eur Radiol. 2016; 26: 3280-3289
        • Brennan M.E.
        • McKessar M.
        • Snook K.
        • Burgess I.
        • Spillane A.J.
        Impact of selective use of breast MRI on surgical decision-making in women with newly diagnosed operable breast cancer.
        Breast. 2017; 32: 135-143
        • McGhan L.J.
        • Wasif N.
        • Gray R.J.
        • Giurescu M.E.
        • Pizzitola V.J.
        • Lorans R.
        • et al.
        Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best?.
        Ann Surg Oncol. 2010; 17: 255-262
        • Heil J.
        • Buehler A.
        • Golatta M.
        • Rom J.
        • Schipp A.
        • Harcos A.
        • et al.
        Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?.
        Ann Oncol. 2012; 23: 98-104
        • Kalli S.
        • Semine A.
        • Cohen S.
        • Naber S.P.
        • Makim S.S.
        • Bahl M.
        American joint committee on cancer’s staging system for breast cancer, eighth edition: what the radiologist needs to know.
        Radiographics. 2018; 38: 1921-1933
        • Monticciolo D.L.
        Practical considerations for the use of breast MRI for breast cancer evaluation in the preoperative setting.
        Acad Radiol. 2017; 24: 1447-1450
        • Lee J.
        • Tanaka E.
        • Eby P.R.
        • Zhou S.
        • Wei W.
        • Eppelheimer C.
        • et al.
        Preoperative breast MRI: surgeons’ patient selection patterns and potential bias in outcomes analyses.
        AJR Am J Roentgenol. 2017; 208: 923-932
        • Lam S.W.
        • Jimenez C.R.
        • Boven E.
        Breast cancer classification by proteomic technologies: current state of knowledge.
        Cancer Treat Rev. 2014; 40: 129-138
        • Testa U.
        • Castelli G.
        • Pelosi E.
        Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments.
        Med Sci (Basel). 2020; 8
        • Grimm L.J.
        • Zhang J.
        • Mazurowski M.A.
        Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
        J Magn Reson Imaging. 2015; 42: 902-907
        • Grimm L.J.
        • Mazurowski M.A.
        Breast cancer radiogenomics: current status and future directions.
        Acad Radiol. 2020; 27: 39-46
        • Zhang X.
        • Wang D.
        • Liu Z.
        • Wang Z.
        • Li Q.
        • Xu H.
        • et al.
        The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer.
        Quant Imaging Med Surg. 2020; 10: 197-210
        • Negrao E.M.S.
        • Souza J.A.
        • Marques E.F.
        • Bitencourt A.G.V.
        Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy.
        Eur J Radiol. 2019; 120108701
        • Leithner D.
        • Bernard-Davila B.
        • Martinez D.F.
        • Horvat J.V.
        • Jochelson M.S.
        • Marino M.A.
        • et al.
        Radiomic signatures derived from diffusion-weighted imaging for the assessment of breast cancer receptor status and molecular subtypes.
        Mol Imaging Biol. 2020; 22: 453-461
        • Surov A.
        • Chang Y.W.
        • Li L.
        • Martincich L.
        • Partridge S.C.
        • Kim J.Y.
        • et al.
        Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
        BMC Cancer. 2019; 19: 1043
        • Montemezzi S.
        • Camera L.
        • Giri M.G.
        • Pozzetto A.
        • Calio A.
        • Meliado G.
        • et al.
        Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?.
        Eur J Radiol. 2018; 108: 120-127
        • Alili C.
        • Pages E.
        • Curros Doyon F.
        • Perrochia H.
        • Millet I.
        • Taourel P.
        Correlation between MR imaging - prognosis factors and molecular classification of breast cancers.
        Diagn Interv Imaging. 2014; 95: 235-242
        • Ha R.
        • Jin B.
        • Mango V.
        • Friedlander L.
        • Miloshev V.
        • Malak S.
        • et al.
        Breast cancer molecular subtype as a predictor of the utility of preoperative MRI.
        AJR Am J Roentgenol. 2015; 204: 1354-1360
        • Grimm L.J.
        • Johnson K.S.
        • Marcom P.K.
        • Baker J.A.
        • Soo M.S.
        Can breast cancer molecular subtype help to select patients for preoperative MR imaging?.
        Radiology. 2015; 274: 352-358
        • Bitencourt A.G.
        • Pereira N.P.
        • França L.K.
        • Silva C.B.
        • Paludo J.
        • Paiva H.L.
        • et al.
        Role of MRI in the staging of breast cancer patients: does histological type and molecular subtype matter?.
        Br J Radiol. 2015; 8820150458
        • Plaza M.J.
        • Handa P.
        • Esserman L.E.
        Preoperative MRI evaluation of axillary lymph nodes in invasive ductal carcinoma: comparison of luminal a versus luminal B subtypes in a paradigm using Ki-67 and receptor status.
        AJR Am J Roentgenol. 2017; 208: 910-915
        • Presta M.
        • Dell’Era P.
        • Mitola S.
        • Moroni E.
        • Ronca R.
        • Rusnati M.
        Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
        Cytokine Growth Factor Rev. 2005; 16: 159-178
        • Mazurowski M.A.
        • Zhang J.
        • Grimm L.J.
        • Yoon S.C.
        • Silber J.I.
        Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
        Radiology. 2014; 273: 365-372
        • Houssami N.
        • Ciatto S.
        • Macaskill P.
        • Lord S.J.
        • Warren R.M.
        • Dixon J.M.
        • et al.
        Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer.
        J Clin Oncol. 2008; 26: 3248-3258
        • Prat A.
        • Pineda E.
        • Adamo B.
        • Galván P.
        • Fernández A.
        • Gaba L.
        • et al.
        Clinical implications of the intrinsic molecular subtypes of breast cancer.
        Breast. 2015; 24: S26-S35
        • Morrow M.
        • Hawley S.T.
        • McLeod M.C.
        • Hamilton A.S.
        • Ward K.C.
        • Katz S.J.
        • et al.
        Surgeon attitudes and use of MRI in patients newly diagnosed with breast cancer.
        Ann Surg Oncol. 2017; 24: 1889-1896
        • Parker A.
        • Schroen A.T.
        • Brenin D.R.
        MRI utilization in newly diagnosed breast cancer: a survey of practicing surgeons.
        Ann Surg Oncol. 2013; 20: 2600-2606
        • Lam D.L.
        • Smith J.
        • Partridge S.C.
        • Kim A.
        • Javid S.H.
        • Hippe D.S.
        • et al.
        The impact of preoperative breast MRI on surgical management of women with newly diagnosed ductal carcinoma in situ.
        Acad Radiol. 2019; 27: 478-486